RecruitingNot ApplicableNCT06679569

Deep Neuromuscular Blockade on Postoperative Pain

Effect of Deep Neuromuscular Blockade on Postoperative Pain in Pediatric Patients Undergoing Laparoscopic Surgery: a Prospective Randomized Controlled Trial


Sponsor

Seoul National University Hospital

Enrollment

106 participants

Start Date

Nov 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to investigate the impact of varying degrees of neuromuscular blockade on postoperative pain in pediatric patients aged over 2 months to under 7 years undergoing laparoscopic surgery under general anesthesia.


Eligibility

Min Age: 2 MonthsMax Age: 7 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called rocuronium 0.2 mg/kg/hr continuous infusion and a drug called rocuronium 0.6 mg/kg/hr continuous infusion for people with neuromuscular blockade. The study is currently recruiting participants at 1 location. People eligible for this study include aged 2 Months to 7 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGrocuronium 0.2 mg/kg/hr continuous infusion

To maintain Train-of-four count 1 to 3 during surgery: Administration of continuous infusion of rocuronium at a rate of 0.2 mg/kg/hr to achieve and sustain moderate neuromuscular blockade.

DRUGrocuronium 0.6 mg/kg/hr continuous infusion

To maintain Train-of-four count 0 during surgery: Administration of continuous infusion of rocuronium at a rate of 0.6 mg/kg/hr to achieve and sustain deep neuromuscular blockade.


Locations(1)

SNUCH

Seoul, Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06679569


Related Trials